Phase 3 Anxiety trials recruiting now

All Anxiety trials, every phase

Other phases for Anxiety

Phase 3 Anxiety trials

• A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
  NCT07807865 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07759128 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07767903 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorders
  NCT07018791 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
  NCT07123467 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
  NCT05772104 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
  NCT07477990 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
  NCT05474846 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
  NCT06053567 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial
  NCT07413055 · Phase: Phase 3 · Ages: 21 Years to 80 Years · Sex: All (male and female) · 1 location
• Creatine for Depressed Male and Female Methamphetamine Users
  NCT02568878 · Phase: Phase 3 · Ages: 18 Years to 59 Years · Sex: All (male and female) · 1 location
• Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi Arabia
  NCT06765057 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
  NCT05681572 · Phase: Phase 3 · Ages: 7 Years to 18 Years · Sex: All (male and female) · 1 location
• Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
  NCT06273527 · Phase: Phase 2, Phase 3 · Ages: 21 Years to 55 Years · Sex: All (male and female) · 1 location
• Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
  NCT06799351 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Nebulized Ketamine for the Treatment of Major Depressive Disorder
  NCT06752759 · Phase: Phase 3 · Ages: 18 Years to 88 Years · Sex: All (male and female) · 1 location
• Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
  NCT06706544 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
  NCT06074250 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 43 Years · Sex: Female · 2 locations
• Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
  NCT06243640 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
  NCT06243614 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
  NCT07280065 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.